Managing systemic mycoses in the compromised host.
D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D008722:Methods; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy; D014181:Transplantation Immunology
D000935:Antifungal Agents; D000970:Antineoplastic Agents